Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-01-20
1986-03-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514908, 544312, A61K 31505, C07D23954
Patent
active
045769486
ABSTRACT:
New uracil compounds having the formula: ##STR1## wherein X is C.sub.1 -C.sub.10 alkoxy or amino are provided. These compounds are useful in treating patients having leukemia, the cells of which express terminal deoxynucleootidyl transferase.
REFERENCES:
Wright et al, Journal of Med. Chemistry, vol. 23 (1), (Jan. 1980) pp. 34-38.
Paul et al, Chemical Abstracts, vol. 61, (1964), 5642(g)-5643(a).
Baril Earl F.
McCaffrey Ronald
Wright George
Cook Paul J.
Daus Donald G.
Gilbert Lawrence
Kapner S.
Trustees Boston University
LandOfFree
Composition and method for inhibiting terminal deoxyribonucleoti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for inhibiting terminal deoxyribonucleoti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for inhibiting terminal deoxyribonucleoti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2306281